These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan. Moser W; Fahal MAH; Abualas E; Bedri S; Elsir MT; Mohamed MFERO; Mahmoud AB; Ahmad AII; Adam MA; Altalib S; DafaAllah OA; Hmed SA; Azman AS; Ciglenecki I; Gignoux E; González A; Mwongera C; Miranda MA Emerg Infect Dis; 2022 May; 28(5):1026-1030. PubMed ID: 35450565 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021. Park AK; Kim IH; Man Kim H; Lee H; Lee NJ; Kim JA; Woo S; Lee CY; Lee J; Oh SJ; Rhee J; Yoo CK; Kim EJ Emerg Infect Dis; 2022 Feb; 28(2):415-419. PubMed ID: 35076365 [TBL] [Abstract][Full Text] [Related]
4. COVID-19: seroprevalence and adherence to preventive measures in Arkhangelsk, Northwest Russia. Krieger E; Sharashova E; Kudryavtsev AV; Samodova O; Kontsevaya A; Brenn T; Postoev V Infect Dis (Lond); 2023 May; 55(5):316-327. PubMed ID: 36919829 [TBL] [Abstract][Full Text] [Related]
6. [Seroprevalence of anti S1 SARS-CoV-2 antibodies in workers vaccinated with Sputnik V at a public hospital in Buenos Aires]. Rovere P; Laurelli A; Díaz A; Dabusti G; Valdez P Medicina (B Aires); 2021; 81(6):895-901. PubMed ID: 34875585 [TBL] [Abstract][Full Text] [Related]
7. Spread of SARS-CoV-2 Variants on Réunion Island, France, 2021. Mercier A; Wilkinson DA; Lebarbenchon C; Mavingui P; Yemadje-Menudier L Emerg Infect Dis; 2022 Apr; 28(4):895-898. PubMed ID: 35319434 [TBL] [Abstract][Full Text] [Related]
9. Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021. Curtis SJ; Shah AW; Ratu A; Wilson DJ; Hill PC; Hulcome P; Gaylard C; Faktaufon D; Cabemaiwai T; Rabukawaqa I; Qoriniasi T; Narayan A; Nakalevu S; Romakin P; Tudravu J; Fong J; Walsh N Emerg Infect Dis; 2023 Jan; 29(1):226-228. PubMed ID: 36573643 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Infection in a Hippopotamus, Hanoi, Vietnam. Bui VN; Dao TD; Tran LH; Vu TT; Nguyen TH; Nguyen GH; Tran KVD; Nguyen HX; Bui AN; Unger F; Nguyen-Viet H; Lee HS Emerg Infect Dis; 2023 Mar; 29(3):658-661. PubMed ID: 36823956 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea. Lee H; Sung HK; Lee D; Choi Y; Lee JY; Lee JY; Oh MD Emerg Infect Dis; 2022 Feb; 28(2):347-353. PubMed ID: 35076368 [TBL] [Abstract][Full Text] [Related]
12. Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon. Ndongo FA; Guichet E; Mimbé ED; Ndié J; Pelloquin R; Varloteaux M; Esemu L; Mpoudi-Etame M; Lamare N; Edoul G; Wouambo RK; Djomsi DM; Tongo M; Tabala FN; Dongmo RK; Diallo MSK; Bouillin J; Thaurignac G; Ayouba A; Peeters M; Delaporte E; Bissek AZ; Mpoudi-Ngolé E Emerg Infect Dis; 2022 Jun; 28(6):1233-1236. PubMed ID: 35470795 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021. Giuliano AR; Pilon-Thomas S; Schell MJ; Abrahamsen M; Islam JY; Isaacs-Soriano K; Kennedy K; Dukes CW; Whiting J; Rathwell J; Hensel JA; Mangual LN; Schonbrunn E; Bikowitz M; Grassie D; Yang Y Emerg Infect Dis; 2022 Mar; 28(3):556-563. PubMed ID: 35081021 [TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020. Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA. Dileepan M; Di D; Huang Q; Ahmed S; Heinrich D; Ly H; Liang Y Virulence; 2021 Dec; 12(1):1597-1609. PubMed ID: 34125647 [TBL] [Abstract][Full Text] [Related]
18. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022. Yamayoshi S; Iwatsuki-Horimoto K; Okuda M; Ujie M; Yasuhara A; Murakami J; Duong C; Hamabata T; Ito M; Chiba S; Kobayashi R; Takahashi S; Mitamura K; Hagihara M; Shibata A; Uwamino Y; Hasegawa N; Ebina T; Izumi A; Kato H; Nakajima H; Sugaya N; Seki Y; Iqbal A; Kamimaki I; Yamazaki M; Kawaoka Y; Furuse Y Emerg Infect Dis; 2022 Nov; 28(11):2198-2205. PubMed ID: 36198306 [TBL] [Abstract][Full Text] [Related]
19. Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona. Jehn M; Pandit U; Sabin S; Tompkins C; White J; Kaleta E; Dale AP; Ross HM; Mac McCullough J; Pepin S; Kenny K; Sanborn H; Heywood N; Schnall AH; Lant T; Sunenshine R Am J Public Health; 2022 Jan; 112(1):38-42. PubMed ID: 34936397 [TBL] [Abstract][Full Text] [Related]